Abstract
Summary
Risperdal (generic name risperidone) is an antipsychotic drug prescribed to treat schizophrenia, bipolar disorder and some behavioral problems in children with autism. It works by changing the effects of chemicals in the brain. It rebalances dopamine and serotonin to potentially improve mood, behavior and thinking.
The global market for Risperidone was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Risperidone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Risperidone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Risperidone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Risperidone include Pharaonia Pharmaceuticals, Aurobindo Pharma, Wellona Pharma, Hikma Pharmaceuticals, Janssen Pharmaceuticals, Amneal Pharmaceuticals and Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Risperidone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Risperidone by region & country, by Type, and by Application.
The Risperidone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Risperidone.
Market Segmentation
By Company
Pharaonia Pharmaceuticals
Aurobindo Pharma
Wellona Pharma
Hikma Pharmaceuticals
Janssen Pharmaceuticals
Amneal Pharmaceuticals
Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
Segment by Type:
Tablets
Solution
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Risperidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Risperidone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Risperidone was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Risperidone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Risperidone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Risperidone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Risperidone include Pharaonia Pharmaceuticals, Aurobindo Pharma, Wellona Pharma, Hikma Pharmaceuticals, Janssen Pharmaceuticals, Amneal Pharmaceuticals and Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Risperidone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Risperidone by region & country, by Type, and by Application.
The Risperidone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Risperidone.
Market Segmentation
By Company
Pharaonia Pharmaceuticals
Aurobindo Pharma
Wellona Pharma
Hikma Pharmaceuticals
Janssen Pharmaceuticals
Amneal Pharmaceuticals
Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
Segment by Type:
Tablets
Solution
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Risperidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Risperidone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Risperidone Product Introduction
1.2 Global Risperidone Market Size Forecast
1.2.1 Global Risperidone Sales Value (2019-2030)
1.2.2 Global Risperidone Sales Volume (2019-2030)
1.2.3 Global Risperidone Sales Price (2019-2030)
1.3 Risperidone Market Trends & Drivers
1.3.1 Risperidone Industry Trends
1.3.2 Risperidone Market Drivers & Opportunity
1.3.3 Risperidone Market Challenges
1.3.4 Risperidone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Risperidone Players Revenue Ranking (2023)
2.2 Global Risperidone Revenue by Company (2019-2024)
2.3 Global Risperidone Players Sales Volume Ranking (2023)
2.4 Global Risperidone Sales Volume by Company Players (2019-2024)
2.5 Global Risperidone Average Price by Company (2019-2024)
2.6 Key Manufacturers Risperidone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Risperidone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Risperidone
2.9 Risperidone Market Competitive Analysis
2.9.1 Risperidone Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Risperidone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablets
3.1.2 Solution
3.1.3 Others
3.2 Global Risperidone Sales Value by Type
3.2.1 Global Risperidone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Risperidone Sales Value, by Type (2019-2030)
3.2.3 Global Risperidone Sales Value, by Type (%) (2019-2030)
3.3 Global Risperidone Sales Volume by Type
3.3.1 Global Risperidone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Risperidone Sales Volume, by Type (2019-2030)
3.3.3 Global Risperidone Sales Volume, by Type (%) (2019-2030)
3.4 Global Risperidone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Risperidone Sales Value by Application
4.2.1 Global Risperidone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Risperidone Sales Value, by Application (2019-2030)
4.2.3 Global Risperidone Sales Value, by Application (%) (2019-2030)
4.3 Global Risperidone Sales Volume by Application
4.3.1 Global Risperidone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Risperidone Sales Volume, by Application (2019-2030)
4.3.3 Global Risperidone Sales Volume, by Application (%) (2019-2030)
4.4 Global Risperidone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Risperidone Sales Value by Region
5.1.1 Global Risperidone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Risperidone Sales Value by Region (2019-2024)
5.1.3 Global Risperidone Sales Value by Region (2025-2030)
5.1.4 Global Risperidone Sales Value by Region (%), (2019-2030)
5.2 Global Risperidone Sales Volume by Region
5.2.1 Global Risperidone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Risperidone Sales Volume by Region (2019-2024)
5.2.3 Global Risperidone Sales Volume by Region (2025-2030)
5.2.4 Global Risperidone Sales Volume by Region (%), (2019-2030)
5.3 Global Risperidone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Risperidone Sales Value, 2019-2030
5.4.2 North America Risperidone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Risperidone Sales Value, 2019-2030
5.5.2 Europe Risperidone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Risperidone Sales Value, 2019-2030
5.6.2 Asia Pacific Risperidone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Risperidone Sales Value, 2019-2030
5.7.2 South America Risperidone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Risperidone Sales Value, 2019-2030
5.8.2 Middle East & Africa Risperidone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Risperidone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Risperidone Sales Value
6.2.1 Key Countries/Regions Risperidone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Risperidone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Risperidone Sales Value, 2019-2030
6.3.2 United States Risperidone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Risperidone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Risperidone Sales Value, 2019-2030
6.4.2 Europe Risperidone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Risperidone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Risperidone Sales Value, 2019-2030
6.5.2 China Risperidone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Risperidone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Risperidone Sales Value, 2019-2030
6.6.2 Japan Risperidone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Risperidone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Risperidone Sales Value, 2019-2030
6.7.2 South Korea Risperidone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Risperidone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Risperidone Sales Value, 2019-2030
6.8.2 Southeast Asia Risperidone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Risperidone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Risperidone Sales Value, 2019-2030
6.9.2 India Risperidone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Risperidone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pharaonia Pharmaceuticals
7.1.1 Pharaonia Pharmaceuticals Company Information
7.1.2 Pharaonia Pharmaceuticals Introduction and Business Overview
7.1.3 Pharaonia Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pharaonia Pharmaceuticals Risperidone Product Offerings
7.1.5 Pharaonia Pharmaceuticals Recent Development
7.2 Aurobindo Pharma
7.2.1 Aurobindo Pharma Company Information
7.2.2 Aurobindo Pharma Introduction and Business Overview
7.2.3 Aurobindo Pharma Risperidone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Aurobindo Pharma Risperidone Product Offerings
7.2.5 Aurobindo Pharma Recent Development
7.3 Wellona Pharma
7.3.1 Wellona Pharma Company Information
7.3.2 Wellona Pharma Introduction and Business Overview
7.3.3 Wellona Pharma Risperidone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Wellona Pharma Risperidone Product Offerings
7.3.5 Wellona Pharma Recent Development
7.4 Hikma Pharmaceuticals
7.4.1 Hikma Pharmaceuticals Company Information
7.4.2 Hikma Pharmaceuticals Introduction and Business Overview
7.4.3 Hikma Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Hikma Pharmaceuticals Risperidone Product Offerings
7.4.5 Hikma Pharmaceuticals Recent Development
7.5 Janssen Pharmaceuticals
7.5.1 Janssen Pharmaceuticals Company Information
7.5.2 Janssen Pharmaceuticals Introduction and Business Overview
7.5.3 Janssen Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Janssen Pharmaceuticals Risperidone Product Offerings
7.5.5 Janssen Pharmaceuticals Recent Development
7.6 Amneal Pharmaceuticals
7.6.1 Amneal Pharmaceuticals Company Information
7.6.2 Amneal Pharmaceuticals Introduction and Business Overview
7.6.3 Amneal Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Amneal Pharmaceuticals Risperidone Product Offerings
7.6.5 Amneal Pharmaceuticals Recent Development
7.7 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
7.7.1 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Company Information
7.7.2 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Introduction and Business Overview
7.7.3 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Product Offerings
7.7.5 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Risperidone Industrial Chain
8.2 Risperidone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Risperidone Sales Model
8.5.2 Sales Channel
8.5.3 Risperidone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer